Botox Tops Topiramate for Chronic Migraine Prevention

  OnabotulinumtoxinA (Botox, Allergan) treatment is more effective, is better tolerated, and has greater functional improvement in the prevention of chronic migraine compared with the anticonvulsant topiramate, new research suggests. In a 36-week head-to-head, prospective, open-label study, investigators found a greater proportion of patients in the onabotulinumtoxinA group (40%) achieved the primary outcome of a … Συνεχίστε να διαβάζετε Botox Tops Topiramate for Chronic Migraine Prevention.

In May TV spending, Sunovion jumps to 2nd, but AbbVie easily keeps top spot

While Humira held its ad spending crown yet again in May, Latuda jumped up to knock Lyrica from the No. 2 spot it's held for the past few months. Sunovion started revving up its Latuda outlays in April, but jacked up spending by 67% in May, according to data from real-time TV ad tracker iSpot.tv. What's … Συνεχίστε να διαβάζετε In May TV spending, Sunovion jumps to 2nd, but AbbVie easily keeps top spot.